Picture of Puma Biotechnology logo

PBYI — Puma Biotechnology News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapSuper Stock

Puma Biotechnology Inc reports results for the quarter ended in December - Earnings Summary

* Puma Biotechnology Inc  PBYI.OQ  reported quarterly
adjusted
earnings of 26 cents​​ per share for the quarter ended in
December, higher than the same quarter last year, when the
company reported EPS of -12 cents.  The mean expectation of
three analysts for the quarter was for earnings of 30 cents per
share. Wall Street expected results to range from 27 cents to 35
cents per share.
    * Revenue rose 9.9% to $72.20 million from a year ago;
analysts
expected $73.55 million. 
    * Puma Biotechnology Inc's reported EPS for the quarter was
26
cents​.
    * The company reported quarterly net income of $12.3
million.
    * Puma Biotechnology Inc shares had risen by 52.4% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "hold"

Wall Street's median 12-month price target for Puma
Biotechnology Inc is $4.00 
This summary was machine generated from LSEG data February 29 at
10:00 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      0.30           0.26           Missed
 Sep. 30 2023      0.08           0.12           Beat
 Jun. 30 2023      0.01           0.05           Beat
 Mar. 31 2023      -0.07          0.03           Beat

Recent news on Puma Biotechnology

See all news